Eckert & Ziegler again with Record Results
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Quarter Results
Corporate news transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Berlin, 7 November 2006. Eckert & Ziegler Strahlen- und Medizintechnik AG
(ISIN DE0005659700), a specialist for cancer radiation systems and
radiometric technology, has posted results of 2.1 million EUR or 0.67 EUR
per share after taxes and distribution to other shareholders for the
nine-month period ending September 30. Third-quarter sales reached the
record mark of more than 12 million EUR, putting the total for the business
year thus far at 36 million EUR (compared to last year's figure of 30
million EUR). Growth was especially dynamic for prostate cancer implants
and tumor radiation systems.
The Board anticipates results of approximately 2.5 million EUR or around
0.80 EUR per share for the full year, representing an increase of around
57% over last year. Nearly 50 million EUR of sales are expected for 2006.
More details on the profit/loss account and balance sheet will be released
with the quarterly report on 7 November.
Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax –112
E-mail: karolin.riehle@ezag.de
www.ezag.de
DGAP 07.11.2006
----------------------------------------------------------------------
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
WWW: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin-Bremen, Stuttgart, München, Hamburg, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------